Chronic obstructive pulmonary disease: molecular and cellular mechanisms, Eur Respir J, vol.20054079, pp.672-688, 2003. ,
DOI : 10.1201/b14103
Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation, J Immunol, vol.154, pp.335-344, 1995. ,
Role for macrophage inflammatory protein-2 in lipopolysaccharideinduced lung injury in rats, J Immunol, vol.156, pp.1963-1972, 1996. ,
Role of the type 1 TNF receptor in lung inflammation after inhalation of endotoxin or Pseudomonas aeruginosa, Am J Physiol, vol.276, pp.715-742, 1999. ,
Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo, J Immunol, vol.163, pp.1537-1544, 1999. ,
Cytokine-mediated inflammation in acute lung injury, Cytokine & Growth Factor Reviews, vol.14, issue.6, pp.523-535, 2003. ,
DOI : 10.1016/S1359-6101(03)00059-5
Repeated endotoxin exposure induces interstitial fibrosis associated with enhanced gelatinase (MMP-2 and MMP-9) activity, Inflammation Research, vol.50, issue.3, pp.129-135, 2001. ,
DOI : 10.1007/s000110050736
The Selective Phosphodiesterase 4 Inhibitor RP 73-401 Reduced Matrix Metalloproteinase 9 Activity and Transforming Growth Factor-beta Release During Acute Lung Injury in Mice: The Role of the Balance Between Tumor Necrosis Factor-alpha and Interleukin-10, Journal of Pharmacology and Experimental Therapeutics, vol.301, issue.1, pp.258-265, 2002. ,
DOI : 10.1124/jpet.301.1.258
Matrix Metalloproteinases, Journal of Biological Chemistry, vol.274, issue.31, pp.21491-21494, 1999. ,
DOI : 10.1074/jbc.274.31.21491
The Matrix Metalloproteinases and Their Inhibitors, American Journal of Respiratory Cell and Molecular Biology, vol.7, issue.2, pp.120-125, 1992. ,
DOI : 10.1165/ajrcmb/7.2.120
Matrix Metalloproteinases, American Journal of Respiratory Cell and Molecular Biology, vol.20, issue.6, pp.1100-1102, 1999. ,
DOI : 10.1165/ajrcmb.20.6.f151
Pulmonary inflammation and tissue remodelling : role of metalloproteinases, Eur Respir Rev, vol.10, pp.260-263, 2000. ,
The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs?, Inflammation Research, vol.52, issue.3, pp.95-100, 2003. ,
DOI : 10.1007/s000110300020
Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.32, issue.2, pp.217-223, 2002. ,
DOI : 10.1159/000053598
Increased Release of Matrix Metalloproteinase-9 in Bronchoalveolar Lavage Fluid and by Alveolar Macrophages of Asthmatics, American Journal of Respiratory Cell and Molecular Biology, vol.17, issue.5, pp.583-591, 1997. ,
DOI : 10.1165/ajrcmb.17.5.2562
Upregulation of Gelatinases A and B, Collagenases 1 and 2, and Increased Parenchymal Cell Death in COPD, Chest, vol.117, issue.3, pp.684-694, 2000. ,
DOI : 10.1378/chest.117.3.684
Sputum Metalloproteinase-9/Tissue Inhibitor of Metalloproteinase-1 Ratio Correlates with Airflow Obstruction in Asthma and Chronic Bronchitis, American Journal of Respiratory and Critical Care Medicine, vol.158, issue.6, pp.1945-1950, 1998. ,
DOI : 10.1164/ajrccm.158.6.9803014
Peroxisome Proliferator-Activated Receptors: Nuclear Control of Metabolism, Endocrine Reviews, vol.20, issue.5, pp.649-688, 1999. ,
DOI : 10.1210/er.20.5.649
Nuclear Receptors and the Control of Metabolism, Annual Review of Physiology, vol.65, issue.1, pp.261-311, 2002. ,
DOI : 10.1146/annurev.physiol.65.092101.142528
The PPAR?????leukotriene B4 pathway to inflammation control, Nature, vol.384, issue.6604, pp.39-43, 1996. ,
DOI : 10.1038/384039a0
Peroxisome Proliferator-activated Receptor ?? Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-??B and AP-1, Journal of Biological Chemistry, vol.274, issue.45, pp.32048-32054, 1999. ,
DOI : 10.1074/jbc.274.45.32048
Topical Peroxisome Proliferator Activated Receptor-?? Activators Reduce Inflammation in Irritant and Allergic Contact Dermatitis Models11The authors declared no conflict of interest., Journal of Investigative Dermatology, vol.118, issue.1, pp.94-101, 2002. ,
DOI : 10.1046/j.0022-202x.2001.01626.x
Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment ,
Activation of PPAR?? or ?? Reduces Secretion of Matrix Metalloproteinase 9 but Not Interleukin 8 from Human Monocytic THP-1 Cells, Biochemical and Biophysical Research Communications, vol.267, issue.1, pp.345-349, 2000. ,
DOI : 10.1006/bbrc.1999.1968
Inhibition of Cytokine-induced Matrix Metalloproteinase 9 Expression by Peroxisome Proliferator-activated Receptor alpha Agonists Is Indirect and Due to a NO-mediated Reduction of mRNA Stability, Journal of Biological Chemistry, vol.277, issue.36, pp.33518-33528, 2002. ,
DOI : 10.1074/jbc.M202008200